{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    6,
    8,
    17,
    20,
    25,
    26,
    29,
    37,
    38,
    39
  ],
  "modelUsed": "gemini-2.5-pro",
  "confidence": 0.8,
  "amendmentDetails": {
    "studyAmendmentImpacts": [
      {
        "id": "impact_1",
        "amendmentId": "amend_3.1_US",
        "affectedSection": "Section 1.3 Schedule of Activities (SoA), Table 1",
        "impactLevel": "Major",
        "instanceType": "StudyAmendmentImpact",
        "description": "Addition of a footnote to the Schedule of Activities to accommodate US-specific screening-only sites."
      },
      {
        "id": "impact_2",
        "amendmentId": "amend_3.1_US",
        "affectedSection": "Section 4.2 - Scientific Rationale for Study Design",
        "impactLevel": "Administrative",
        "instanceType": "StudyAmendmentImpact",
        "description": "A numerical value was changed to align text with other sections of the protocol for consistency."
      },
      {
        "id": "impact_3",
        "amendmentId": "amend_3.1_US",
        "affectedSection": "Section 8 - Study Assessments and Procedures",
        "impactLevel": "Major",
        "instanceType": "StudyAmendmentImpact",
        "description": "Introduced a new operational procedure allowing certain US sites to perform only screening activities."
      }
    ],
    "studyAmendmentReasons": [
      {
        "id": "reason_1",
        "amendmentId": "amend_3.1_US",
        "reasonText": "To clarify study procedures occurring across different sites in the US, so as to facilitate participant recruitment across different regions of the US, and to lessen inconvenience for participants without compromising the quality of the study.",
        "category": "Operational",
        "isPrimary": true,
        "instanceType": "StudyAmendmentReason"
      },
      {
        "id": "reason_2",
        "amendmentId": "amend_3.1_US",
        "reasonText": "To align the number of days with the mention of zinc discontinuation elsewhere in the protocol.",
        "category": "Administrative",
        "isPrimary": false,
        "instanceType": "StudyAmendmentReason"
      }
    ],
    "studyChanges": [
      {
        "id": "change_1",
        "amendmentId": "amend_3.1_US",
        "changeType": "Addition",
        "instanceType": "StudyChange",
        "sectionNumber": "1.3",
        "afterText": "Text added to the footnote to state that procedures specific to screening sites (only in the US) detailed in Section 8.",
        "summary": "A footnote was added to the Schedule of Activities (Table 1) to reference US-specific screening procedures in Section 8."
      },
      {
        "id": "change_2",
        "amendmentId": "amend_3.1_US",
        "changeType": "Modification",
        "instanceType": "StudyChange",
        "sectionNumber": "4.2",
        "beforeText": "...the inhibitory effect of zinc on intestinal copper absorption is expected to be minimal 30 days after discontinuation of zinc.",
        "afterText": "...the inhibitory effect of zinc on intestinal copper absorption is expected to be minimal 21 days after discontinuation of zinc.",
        "summary": "The number of days for the expected minimal inhibitory effect of zinc was changed from 30 to 21 for consistency."
      },
      {
        "id": "change_3",
        "amendmentId": "amend_3.1_US",
        "changeType": "Addition",
        "instanceType": "StudyChange",
        "sectionNumber": "8",
        "afterText": "Text applicable only to the US that details the possibility for sites in the US to only perform screening procedures and not any of the remaining study procedures.",
        "summary": "New text was added to allow US sites to function as screening-only sites to aid recruitment."
      }
    ],
    "summary": {
      "impactCount": 3,
      "reasonCount": 2,
      "changeCount": 3
    }
  }
}